COSM stock icon

Cosmos Holdings


About: Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.

Employees: 102

Funds holding %
of 6,665 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

11.1% less ownership

Funds ownership: 14.68% [Q4 2023] → 3.57% (-11.1%) [Q1 2024]

18% less funds holding

Funds holding: 17 [Q4 2023] → 14 (-3) [Q1 2024]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

85% less capital invested

Capital invested by funds: $2.77M [Q4 2023] → $429K (-$2.34M) [Q1 2024]

Research analyst outlook

We haven’t received any recent analyst ratings for COSM.

Financial journalist opinion